IL-33 Exacerbates Endometriotic Lesions via Polarizing Peritoneal Macrophages to M2 Subtype

Yosuke Ono1,2, Osamu Yoshino3, Takehiro Hiraoka4

  • 1Department of Obstetrics and Gynecology, University of Toyama, Toyoma, Japan.

Insights

Interleukin-33 (IL-33) drives M2 macrophage polarization in endometriosis, promoting lesion growth. This study reveals a cycle where IL-33 from lesions stimulates macrophages, exacerbating the condition.

Area of Science:

  • Reproductive immunology
  • Cellular and molecular biology

Background:

  • M2 macrophages are dominant in endometriosis and promote lesion development.
  • The specific factors inducing M2 macrophage polarization in endometriosis remain largely unknown.

Purpose of the Study:

  • To investigate the role of interleukin-33 (IL-33), an alarmin, in endometriosis.
  • To explore the relationship between IL-33 and macrophage polarization in the context of endometriosis.

Main Methods:

  • Immunohistochemistry to detect IL-33 expression in endometriotic lesions.
  • Measurement of IL-33 concentration in cystic fluid from endometriomas and non-endometriomas.
  • In vitro experiments using endometriotic stromal cells (ESC) and patient-derived macrophages (MΦ).

Main Results:

  • IL-33 was detected in the epithelium and stromal cells of endometriotic lesions.
  • Significantly higher IL-33 concentrations were found in endometrioma cystic fluid compared to non-endometriomas.
  • IL-33 stimulation induced peritoneal MΦ to polarize to M2 phenotype and increase IL-1β mRNA expression, an effect blocked by soluble ST2.

Conclusions:

  • IL-33, originating from endometriotic lesions, promotes M2 macrophage polarization and IL-1β production.
  • A positive feedback loop involving IL-33 and IL-1β may contribute to the exacerbation of endometriosis lesions.

Related Concept Videos